Answers are grounded in this paper and cite their sources.
Background: Elevated ambient temperatures increase the risk for acute kidney-related morbidity, and medication use may increase vulnerability to heat exposure. This study examines whether medication use, and combination medication use (ie, polypharmacy), modifies the risk for temperature-related volume depletion (VD) and acute kidney injury (AKI). Methods: This study uses patient-level emergency department (ED) visit data from four Atlanta-area hospitals during the warm season from 2013 to 2019. ED patient-visits who reported a medication were matched with up to five ED patient-visits without the medication. Medications included angiotensin converting enzymes and angiotensin receptor blockers (ACE/ARBs), anti-depressants, anti-convulsants, β-blockers, diuretics, non-steroidal anti-inflammatory drugs and statins. A case-crossover framework is used to estimate associations between daily maximum temperature, medication use and VD/AKI ED visits. Results: percentiles, patients using antidepressants had a higher risk for AKI (OR 1.28, 95% CI 1.08 to 1.52) compared with antidepressant nonusers (1.03, 95% CI 0.95 to 1.12). Polypharmacy analysis indicated that patients taking statins with ACE/ARBs were at an elevated risk for AKI (OR 1.38, 95% CI 1.02 to 1.86) relative to all other groups. This includes patients taking only an ACE/ARB (OR 1.00, 95% CI 0.82 to 1.21), only a statin (OR 1.10, 95% CI 0.90 to 1.33) or neither medication (OR 1.07, 95% CI 0.93 to 1.23). Conclusion: Results show that both single and combined medication use are associated with elevated risk for VD and AKI during periods of elevated ambient temperature.
No takes yet. Share an insight, caveat, or question.
McCann et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: